22-20425478-G-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_182895.5(SCARF2):āc.2498C>Gā(p.Ala833Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.603 in 1,386,482 control chromosomes in the GnomAD database, including 254,848 homozygotes. In-silico tool predicts a benign outcome for this variant. 10/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_182895.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCARF2 | NM_182895.5 | c.2498C>G | p.Ala833Gly | missense_variant | 11/11 | ENST00000622235.5 | NP_878315.2 | |
SCARF2 | NM_153334.7 | c.2513C>G | p.Ala838Gly | missense_variant | 11/11 | NP_699165.3 | ||
SCARF2 | XM_047441585.1 | c.2612C>G | p.Ala871Gly | missense_variant | 11/11 | XP_047297541.1 | ||
SCARF2 | XM_017029065.3 | c.*727C>G | 3_prime_UTR_variant | 11/11 | XP_016884554.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.600 AC: 91076AN: 151718Hom.: 27772 Cov.: 31
GnomAD3 exomes AF: 0.549 AC: 47156AN: 85938Hom.: 13314 AF XY: 0.558 AC XY: 28089AN XY: 50362
GnomAD4 exome AF: 0.603 AC: 744641AN: 1234656Hom.: 227073 Cov.: 51 AF XY: 0.601 AC XY: 362107AN XY: 602024
GnomAD4 genome AF: 0.600 AC: 91107AN: 151826Hom.: 27775 Cov.: 31 AF XY: 0.600 AC XY: 44540AN XY: 74200
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 06, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Van den Ende-Gupta syndrome Benign:2
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | Jan 15, 2016 | - - |
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at